Riccardo is a NIHR Academic Clinical Fellow in Medical Oncology in Cambridge. He studied Immunology at Imperial College London before reading Graduate Medicine at Wolfson College in Cambridge, where he graduated with Distinction and won several university prizes, including best performance in year 1 and year 2. He holds two national leadership positions and is a Fellow of the Higher Education Academy. His research, conducted in collaboration between the CRUK Cambridge Institute and AstraZeneca, focuses on the analysis of high-throughput drug screens in patient-derived tumour xenograft cells (PDTCs).
Wednesday, 18 June 2025
| Time |
Session |
|
|
15:20
16:55
|
-
Agent-Based Modelling of Gene Networks the tumour microenvironment ecosytem
-
Proffered Paper: High-throughput drug screening in breast cancer PDTCs enables clinically relevant drug discovery for personalised medicine.
EACR25-1681
-
The power of many: Unlocking treatment response patterns through single-cell meta-analysis
-
Proffered Paper: Spatial and multi-omic profiling of HGSC to identify immune vulnerabilities for precision immunotherapy
EACR25-0439
-
Title to be announced
Auditorium I
|
